Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.

Saved in:
Bibliographic Details
Title: Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
Authors: Rothenberg ML; University of Texas Health Science Center at San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu, Sharma A, Weiss GR, Villalona-Calero MA, Eckardt JR, Aylesworth C, Kraynak MA, Rinaldi DA, Rodriguez GI, Burris HA 3rd, Eckhardt SG, Stephens CD, Forral K, Nicol SJ, Von Hoff DD
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1998 Jul; Vol. 9 (7), pp. 733-8.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0923-7534
DOI:10.1023/a:1008286908930